SCHEMBL20176094

SCHEMBL20176094

CC(O)(CCc1ccccc1)C(=O)CCl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
AR P10275 1/20 0.46
ALDH1A1 P00352 2/20 0.44
KEAP1 Q14145 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
ALOX12 P18054 1/20 0.42
CYP2C19 P33261 1/20 0.42
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SSTR4 P31391 1/20 0.41
MMP8 P22894 1/20 0.41
FDPS P14324 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5475208 0.85 ALDH1A1 (0.50) NPC1RAB9APOLBMAPTMEN1
SCHEMBL6632235 0.85 ALDH1A1 (0.50) NPC1RAB9APOLBMAPTMEN1
SCHEMBL6628038 0.85 ALDH1A1 (0.50) NPC1RAB9APOLBMAPTMEN1
SCHEMBL20176115 0.83 NPC1 (0.44) NPC1RAB9APOLBMAPTMEN1
SCHEMBL22781383 0.81 ALDH1A1 (0.52) NPC1RAB9APOLBMAPTMEN1
SCHEMBL6914641 0.80 AR (0.47) NPC1RAB9APOLBMAPTMEN1
SCHEMBL6912517 0.80 AR (0.47) NPC1RAB9APOLBMAPTMEN1
SCHEMBL27957913 0.80 AR (0.47) NPC1RAB9APOLBMAPTMEN1
SCHEMBL20176095 0.79 SLC13A5 (0.45) NPC1RAB9APOLBMAPTMEN1
SCHEMBL20176096 0.78 KMT2A (0.43) NPC1RAB9APOLBMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450331-B2 Functionalized cyanosilane and synthesis method and use thereof EAST CHINA NORMAL UNIVERSITY (CN) 2019-10-22 US disclosed
US-20180141964-A1 FUNCTIONALIZED CYANOSILANE AND SYNTHESIS METHOD AND USE THEREOF EAST CHINA NORMAL UNIVERSITY (CN) 2018-05-24 US disclosed
US-20180141964-A1 FUNCTIONALIZED CYANOSILANE AND SYNTHESIS METHOD AND USE THEREOF EAST CHINA NORMAL UNIVERSITY (CN) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141964-A1 FUNCTIONALIZED CYANOSILANE AND SYNTHESIS METHOD AND USE THEREOF NCLN, PNN, MB NPC1 1862/4885RAB9A 4161/4885POLB 2243/4885
US-10450331-B2 Functionalized cyanosilane and synthesis method and use thereof NCLN, PNN, MB NPC1 1862/4885RAB9A 4161/4885POLB 2243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.